EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+2.92%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$7.56B
AUM Growth
+$7.56B
(+1.6%)
Cap. Flow
+$133M
Cap. Flow
% of AUM
1.75%
Top 10 Holdings %
Top 10 Hldgs %
25.56%
Holding
165
New
13
Increased
52
Reduced
26
Closed
13
Top Buys
| 1 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$59.2M |
| 2 |
FIVE9
FIVN
|
$46.1M |
| 3 |
Xometry
XMTR
|
$42M |
| 4 |
Global E Online
GLBE
|
$34.3M |
| 5 |
Fiverr
FVRR
|
$28.7M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$92.5M |
| 2 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$75.2M |
| 3 |
Celldex Therapeutics
CLDX
|
$53M |
| 4 |
BridgeBio Pharma
BBIO
|
$43.4M |
| 5 |
RingCentral
RNG
|
$33.8M |
Sector Composition
| 1 | Healthcare | 34.45% |
| 2 | Technology | 30.19% |
| 3 | Industrials | 13.01% |
| 4 | Consumer Discretionary | 7.21% |
| 5 | Communication Services | 4.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Veracyte
VCYT
$2.41B
| $30.2M | 0.4% |
651,000
| – | – |
|
77
Cognex
CGNX
$7.43B
| $28.8M | 0.38% |
359,000
| – | – |
|
78
Lennox International
LII
$19.1B
| $27.9M | 0.37% |
95,000
| – | – |
|
79
dLocal
DLO
$4.09B
| $27.6M | 0.36% |
+505,047
| New | +$27.6M |
|
80
Rollins
ROL
$27.3B
| $25.7M | 0.34% |
727,500
| – | – |
|
81
Kura Oncology
KURA
$732M
| $25.5M | 0.34% |
1,361,044
+657,044
| +93% | +$12.3M |
|
82
Coursera
COUR
$1.83B
| $25.3M | 0.33% |
+800,000
| New | +$25.3M |
|
83
nVent Electric
NVT
$14.4B
| $25M | 0.33% |
772,000
+211,500
| +38% | +$6.84M |
|
84
Intuitive Surgical
ISRG
$158B
| $24.9M | 0.33% |
75,000
| – | – |
|
85
Skyworks Solutions
SWKS
$10.9B
| $24.7M | 0.33% |
150,047
+2,000
| +1% | +$330K |
|
|
MRTX
86
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $22.9M | 0.3% |
129,471
| – | – |
|
87
Neurocrine Biosciences
NBIX
$13.5B
| $22.5M | 0.3% |
235,000
| – | – |
|
88
89bio
ETNB
$1.37B
| $22.3M | 0.29% |
1,137,092
| – | – |
|
89
Syndax Pharmaceuticals
SNDX
$1.39B
| $22.3M | 0.29% |
1,165,000
+462,652
| +66% | +$8.84M |
|
90
Guardant Health
GH
$8.11B
| $22.3M | 0.29% |
+178,000
| New | +$22.3M |
|
91
908 Devices
MASS
$214M
| $22.2M | 0.29% |
682,271
+348,988
| +105% | +$11.3M |
|
92
Steris
STE
$23.9B
| $20.7M | 0.27% |
101,500
+12,800
| +14% | +$2.61M |
|
93
Tourmaline Bio
TRML
$645M
| $20.7M | 0.27% |
156,109
| – | – |
|
94
KLA
KLAC
$111B
| $20.5M | 0.27% |
61,398
+20,000
| +48% | +$6.69M |
|
95
MediaAlpha
MAX
$613M
| $20.5M | 0.27% |
1,098,246
-92,366
| -8% | -$1.73M |
|
96
Phathom Pharmaceuticals
PHAT
$843M
| $19.3M | 0.25% |
600,000
| – | – |
|
|
FRC
97
DELISTED
First Republic Bank
FRC
| $19M | 0.25% |
98,600
| – | – |
|
98
Butterfly Network
BFLY
$378M
| $18.5M | 0.24% |
1,776,000
+411,000
| +30% | +$4.29M |
|
99
Prologis
PLD
$103B
| $18.4M | 0.24% |
146,500
+8,300
| +6% | +$1.04M |
|
|
CCXI
100
DELISTED
ChemoCentryx, Inc.
CCXI
| $17.8M | 0.23% |
1,040,000
-363,000
| -26% | -$6.21M |
|